Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial

BACKGROUND: The utility of early metabolic response assessment to guide selection of the systemic component of definitive chemoradiotherapy (dCRT) for oesophageal cancer is uncertain. METHODS: In this multi-centre, randomised, open-label, phase II substudy of the radiotherapy dose-escalation SCOPE2...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Somnath, Hurt, Christopher N., Adams, Richard, Bateman, Andrew, Bradley, Kevin M., Bridges, Sarah, Falk, Stephen, Griffiths, Gareth, Gwynne, Sarah, Jones, Christopher M., Markham, Philip J., Maughan, Tim, Nixon, Lisette S., Radhakrishna, Ganesh, Roy, Rajarshi, Schoenbuchner, Simon, Sheikh, Hamid, Spezi, Emiliano, Hawkins, Maria, Crosby, Thomas D.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318451/
https://www.ncbi.nlm.nih.gov/pubmed/37409323
http://dx.doi.org/10.1016/j.eclinm.2023.102059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318451/
https://www.ncbi.nlm.nih.gov/pubmed/37409323
http://dx.doi.org/10.1016/j.eclinm.2023.102059

Ejemplares similares